Jeff Albers | CEO |
Andy Boral | Chief Medical Officer |
Mike Landsittel | VP of Finance |
Marion Dorsch | Chief Scientific Officer |
Kristin Hodous | IR |
Terence Flynn | Goldman Sachs |
Laura Chico | Raymond James |
Marc Frahm | Cowen and Company |
Konstantinos Aprilakis | JMP Securities |
Arlinda Lee | Canaccord Genuity |
Eun Yang | Jefferies |
Good day, ladies and gentlemen, and welcome to the Second Quarter 2018 Blueprint Medicines Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference call may be recorded.